Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study
(Q43105772)
scientific article published on 6 April 2010
scientific article published on 6 April 2010
Language:
other details
description | scientific article published on 6 April 2010 |
External Links
(P356) |
10.1016/S1470-2045(10)70058-9
|
(P698) |
20378407
|